Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161420216> ?p ?o ?g. }
- W2161420216 endingPage "673" @default.
- W2161420216 startingPage "666" @default.
- W2161420216 abstract "<b>Objectives:</b> There is currently much interest in biomarkers of disease activity in frontotemporal lobar degeneration (FTLD). We assessed MRI and behavioral measures of progression in a longitudinal FTLD cohort. <b>Methods:</b> Thirty-two patients with FTLD (11 behavioral variant frontotemporal dementia [bvFTD], 11 semantic dementia [SemD], 10 progressive nonfluent aphasia [PNFA]) and 24 age-matched healthy controls were assessed using volumetric brain MRI and standard behavioral measures (Mini-Mental State Examination, Frontal Assessment Battery, Clinical Dementia Rating Scale, Neuropsychiatric Inventory with Caregiver Distress scale) at baseline and 1 year later. A semi-automated image registration protocol was used to calculate annualized rates of brain atrophy (brain boundary shift integral [BBSI]) and ventricular expansion (ventricular boundary shift integral [VBSI]). Associations between these rates and changes in behavioral indices were investigated. <b>Results:</b> Rates of whole brain atrophy were greater in the entire FTLD cohort and in each subgroup compared with controls (all <i>p</i> ≤ 0.004). Rates of ventricular expansion were greater in the entire cohort (<i>p</i> < 0.001) and the SemD (<i>p</i> = 0.002) and PNFA (<i>p</i> = 0.05) subgroups compared with controls. Changes in Mini-Mental State Examination, Frontal Assessment Battery, and Clinical Dementia Rating Scale scores were associated with MRI measures of progression, though not uniformly across FTLD subgroups. Both BBSI and VBSI yielded feasible sample size estimates for detecting meaningful treatment effects in SemD and PNFA language subgroups. Sample sizes were substantially larger using MRI biomarkers for the bvFTD subgroup, and using behavioral biomarkers in general. <b>Conclusions:</b> Semi-automated MRI atrophy measures are potentially useful objective biomarkers of progression in frontotemporal lobar degeneration (FTLD); however, careful stratification of FTLD subtypes will be important in future clinical trials of disease-modifying therapies." @default.
- W2161420216 created "2016-06-24" @default.
- W2161420216 creator A5014176628 @default.
- W2161420216 creator A5018836358 @default.
- W2161420216 creator A5032450718 @default.
- W2161420216 creator A5035578674 @default.
- W2161420216 creator A5068675261 @default.
- W2161420216 creator A5070961589 @default.
- W2161420216 creator A5083470216 @default.
- W2161420216 date "2010-02-22" @default.
- W2161420216 modified "2023-10-18" @default.
- W2161420216 title "Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study" @default.
- W2161420216 cites W1847168837 @default.
- W2161420216 cites W1967956494 @default.
- W2161420216 cites W1969605905 @default.
- W2161420216 cites W1974583546 @default.
- W2161420216 cites W1974621282 @default.
- W2161420216 cites W1976473223 @default.
- W2161420216 cites W1980827933 @default.
- W2161420216 cites W1984148891 @default.
- W2161420216 cites W1989274511 @default.
- W2161420216 cites W1991952617 @default.
- W2161420216 cites W1997526132 @default.
- W2161420216 cites W2009105260 @default.
- W2161420216 cites W2010528085 @default.
- W2161420216 cites W2011341635 @default.
- W2161420216 cites W2012763181 @default.
- W2161420216 cites W2025152196 @default.
- W2161420216 cites W2030352680 @default.
- W2161420216 cites W2037431629 @default.
- W2161420216 cites W2040328682 @default.
- W2161420216 cites W2055679607 @default.
- W2161420216 cites W2061821269 @default.
- W2161420216 cites W2079662917 @default.
- W2161420216 cites W2090057077 @default.
- W2161420216 cites W2091173932 @default.
- W2161420216 cites W2106279576 @default.
- W2161420216 cites W2112150247 @default.
- W2161420216 cites W2123983635 @default.
- W2161420216 cites W2127384340 @default.
- W2161420216 cites W2137466608 @default.
- W2161420216 cites W2138011006 @default.
- W2161420216 cites W2148058458 @default.
- W2161420216 cites W2152634927 @default.
- W2161420216 cites W2158521092 @default.
- W2161420216 cites W2171051269 @default.
- W2161420216 doi "https://doi.org/10.1212/wnl.0b013e3181d1a879" @default.
- W2161420216 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2830919" @default.
- W2161420216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20177120" @default.
- W2161420216 hasPublicationYear "2010" @default.
- W2161420216 type Work @default.
- W2161420216 sameAs 2161420216 @default.
- W2161420216 citedByCount "59" @default.
- W2161420216 countsByYear W21614202162012 @default.
- W2161420216 countsByYear W21614202162013 @default.
- W2161420216 countsByYear W21614202162014 @default.
- W2161420216 countsByYear W21614202162015 @default.
- W2161420216 countsByYear W21614202162016 @default.
- W2161420216 countsByYear W21614202162017 @default.
- W2161420216 countsByYear W21614202162018 @default.
- W2161420216 countsByYear W21614202162019 @default.
- W2161420216 countsByYear W21614202162020 @default.
- W2161420216 countsByYear W21614202162021 @default.
- W2161420216 countsByYear W21614202162022 @default.
- W2161420216 countsByYear W21614202162023 @default.
- W2161420216 crossrefType "journal-article" @default.
- W2161420216 hasAuthorship W2161420216A5014176628 @default.
- W2161420216 hasAuthorship W2161420216A5018836358 @default.
- W2161420216 hasAuthorship W2161420216A5032450718 @default.
- W2161420216 hasAuthorship W2161420216A5035578674 @default.
- W2161420216 hasAuthorship W2161420216A5068675261 @default.
- W2161420216 hasAuthorship W2161420216A5070961589 @default.
- W2161420216 hasAuthorship W2161420216A5083470216 @default.
- W2161420216 hasBestOaLocation W21614202162 @default.
- W2161420216 hasConcept C126322002 @default.
- W2161420216 hasConcept C15744967 @default.
- W2161420216 hasConcept C2776939681 @default.
- W2161420216 hasConcept C2778641062 @default.
- W2161420216 hasConcept C2779116556 @default.
- W2161420216 hasConcept C2779134260 @default.
- W2161420216 hasConcept C2779140760 @default.
- W2161420216 hasConcept C2779483572 @default.
- W2161420216 hasConcept C2780906993 @default.
- W2161420216 hasConcept C2781172350 @default.
- W2161420216 hasConcept C71924100 @default.
- W2161420216 hasConcept C72563966 @default.
- W2161420216 hasConceptScore W2161420216C126322002 @default.
- W2161420216 hasConceptScore W2161420216C15744967 @default.
- W2161420216 hasConceptScore W2161420216C2776939681 @default.
- W2161420216 hasConceptScore W2161420216C2778641062 @default.
- W2161420216 hasConceptScore W2161420216C2779116556 @default.
- W2161420216 hasConceptScore W2161420216C2779134260 @default.
- W2161420216 hasConceptScore W2161420216C2779140760 @default.
- W2161420216 hasConceptScore W2161420216C2779483572 @default.
- W2161420216 hasConceptScore W2161420216C2780906993 @default.
- W2161420216 hasConceptScore W2161420216C2781172350 @default.
- W2161420216 hasConceptScore W2161420216C71924100 @default.
- W2161420216 hasConceptScore W2161420216C72563966 @default.